Background
Expression of the homeodomain-containing transcription factor Nkx2-1 is essential for the prenatal development of the forebrain, lungs and thyroid gland. Humans with only one functioning NKX2-1-allele, a rare genetic condition known as “NKX2-1 haploinsufficiency”, become phenotypic in early childhood. This syndrome displays a variable combination of symptoms including congenital hypothyroidism, respiratory distress syndrome and choreoathetosis. The severity of the neurological symptoms varies between the patients but, however, little is known about the cell-types, which might be affected by the mutation. Recently it was shown in mice that cholinergic and parvalbumin (PV)-containing GABAergic neurons of the subcortical basal ganglia and magnocellular nuclei of the ventral forebrain maintain Nkx2-1 synthesis throughout life. It is well-known that postnatal cholinergic basal forebrain neurons are strongly influenced by the synthesis of neurotrophins including the “nerve growth factor” (NGF). For instance, NGF is essential for the differentiation and maintenance of these cells which otherwise, in the absence of this trophic molecule, undergo shrinkage and degeneration. It is also known that cortical GABAergic neurons, which are mostly described as their target cells, synthesize this factor. In order to elucidate whether impaired synthesis of Nkx2-1 is accompanied by corresponding effects on the neurotrophin synthesis, we have investigated conditional knock-out mice with either pre- or postnatal deletion of Nkx2-1. Additionally, we investigated the effects of these two mutations on the synthesis of corresponding neurotrophin receptors (trkA, trkB, p75NTR).
